ADMA Biologics Inc
(NAS:ADMA)
$
11.005
0.01 (0.09%)
Market Cap: 2.55 Bil
Enterprise Value: 2.65 Bil
PE Ratio: 0
PB Ratio: 16.68
GF Score: 65/100 - Q4 2023 ADMA Biologics Inc Earnings Call TranscriptFeb 28, 2024$5.38 (-2.54%)Earnings
- Q3 2023 ADMA Biologics Inc Earnings Call TranscriptNov 08, 2023$3.62 (-1.90%)Earnings
- Q2 2023 ADMA Biologics Inc Earnings Call TranscriptAug 09, 2023$4.06 (-1.93%)Earnings
- Q1 2023 ADMA Biologics Inc Earnings Call TranscriptMay 10, 2023$3.57 (+2.88%)Earnings
- Q4 2022 ADMA Biologics Inc Earnings Call TranscriptMar 23, 2023$3.11 (+3.32%)Earnings
- Q3 2022 ADMA Biologics Inc Earnings Call TranscriptNov 09, 2022$2.47 (-5.36%)Earnings
- Q2 2022 ADMA Biologics Inc Earnings Call TranscriptAug 10, 2022$2.12 (+4.43%)Earnings
- Q1 2022 ADMA Biologics Inc Earnings Call TranscriptMay 11, 2022$1.43 (-11.18%)Earnings
- Q4 2021 ADMA Biologics Inc Earnings Call TranscriptMar 24, 2022$1.5 (+2.74%)Earnings
- Q3 2021 ADMA Biologics Inc Earnings Call TranscriptNov 10, 2021$1.4 (-1.41%)Earnings
- ADMA Biologics Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) TranscriptSep 30, 2021
- ADMA Biologics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 09, 2021
- Q2 2021 ADMA Biologics Inc Earnings Call TranscriptAug 11, 2021$1.53 (-0.65%)Earnings
- ADMA Biologics Inc Annual Shareholders Meeting TranscriptMay 27, 2021
- Q1 2021 ADMA Biologics Inc Earnings Call TranscriptMay 12, 2021$1.67 (-3.47%)Earnings
- Q4 2020 ADMA Biologics Inc Earnings Call TranscriptMar 25, 2021$2.05 (+3.54%)Earnings
- ADMA Biologics Inc at Jefferies Virtual Plasma Summit TranscriptMar 11, 2021
- Q3 2020 ADMA Biologics Inc Earnings Call TranscriptNov 05, 2020$2.11 (-1.40%)Earnings
- ADMA Biologics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2020
- Q2 2020 ADMA Biologics Inc Earnings Call TranscriptAug 05, 2020$3.56 (+5.64%)Earnings
- Q1 2020 ADMA Biologics Inc Earnings Call TranscriptMay 06, 2020$3.2 (+0.95%)Earnings
- Q4 2019 ADMA Biologics Inc Earnings Call TranscriptMar 12, 2020$2.19 (-5.19%)Earnings
ADMA Biologics Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript
Sep 30, 2021 / 01:20PM GMT
Release Date Price:
$1.13
Kristen Kluska
Cantor Fitzgerald - Analyst
Hello, everyone. I am Kristen Kluska, one of the biotechnology analysts at Cantor. It's my pleasure to host ADMA Biologics today. And joining me on this fireside chat are Adam Grossman, the Founder, Director, President and CEO; and Brian Lenz, the Executive Vice President and CFO. Thank you for joining us and for being at our conference today.
Adam Grossman
ADMA Biologics, Inc. - Founder, Director, President & CEO
Thank you so much, Kristen. We appreciate the opportunity to speak with you, and thank you to the Cantor team for the invitation.
Questions & Answers
Kristen Kluska
Cantor Fitzgerald - Analyst
Great, thanks. So for those who are relatively new to this story, could you please describe the benefits of plasma-derived therapies and your three commercial products?
Adam Grossman
ADMA Biologics, Inc. - Founder, Director, President & CEO
Sure. Happy to do so. So yes, we are an end-to-end vertically
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)